Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Vet Immunol Immunopathol. 2014 May 2;160(0):167–176. doi: 10.1016/j.vetimm.2014.04.009

Fig. 3.

Fig. 3

MANS peptide inhibits β2-integrin dependent equine neutrophil adhesion. MANS peptide, but not RNS, demonstrated a dose dependent inhibition of PMA- (A) and IC-mediated (B) equine neutrophil adhesion in vitro. (C) Both MANS 50 μM and αCD18 F(ab1)2 (30 μg/ml shown) significantly inhibited PMA- and IIC-mediated equine neutrophil adhesion. Data presented as mean ± SEM, *p < 0.05 vs. PBS (“MANS 0 μM”), n = 6.